Clinical trial
A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
NCT02360319 is registered in ClinicalTrials.gov with Vanguard Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Cluster Randomized, Multi-center, Parallel-group, Rater-blind Study Comparing Treatment With Aripiprazole Once Monthly and Treatment as Usual on Effectiveness in First Episode and Early Phase Illness in Schizophrenia
- Lead sponsor
- Vanguard Research Group
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 11, 2014
- Completion date
- March 31, 2019
- Enrollment
- 489 (actual)
- Sites
- 39
Conditions
As the registry lists them; a condition with its own page is linked.